Lilly Endowment Files Form 144 to Sell $368.7M in Eli Lilly Common Stock

Overview

On October 15, 2026, Lilly Endowment Inc., a major shareholder of Eli Lilly and Company (NYSE: LLY), filed a Form 144 notice disclosing an intention to sell 305,000 shares of common stock through Fidelity Capital Markets, with an estimated market value of $368,665,700 (~$1,208.74 per share).

Historical Context & Recent Sales

• Acquisition Origin: The shares originate from a historical gift received on February 10, 1948, from the J.K. Lilly Sr. Trust.
• Past 3 Months Activity: Lilly Endowment has maintained an active liquidation schedule in the preceding 90 days:
  • August 13, 2026: 122 shares for $151,280
  • August 19, 2026: 302,403 shares for $385,708,676.04
  • October 7, 2026: 28,357 shares for $34,117,815.29
  • October 14, 2026: 271,643 shares for $328,823,634.19
  • Total 3-month proceeds realized prior to this notice: ~$748.8 million.

Impact & Significance

• Scale: With 941,357,065 shares outstanding, the 305,000 shares represent approximately 0.032% of total shares outstanding, presenting minimal dilution or float disruption despite the sizable nominal value ($368.7M).
• Nature of the Seller: As a philanthropic private foundation, Lilly Endowment routinely monetizes equity holdings to fund charitable grantmaking and comply with non-profit distribution requirements. While this represents a high dollar value, the selling pattern reflects programmatic philanthropic funding rather than fundamental shifts in corporate outlook.